Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
By Alan S. Go, E. Hylek, Katherine Phillips, Yuchiao Chang, Lori Henault, J. Selby, Daniel E. Singer. Journal of the American Medical Association (JAMA), 2001
6,602 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/1e63e16b0fa156472b250959b44c4287e8e48b01
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- D. Lloyd‐Jones
- Ramachandran S. Vasan
- Emelia J. Benjamin
- Daniel Levy
- S. Malnick
- H. Knobler
- Dobromir Petkov Dobrev
- Ralph B. D’Agostino
Citations in the corpus
- A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. (2003, background): “As the population ages and the prevalence of cardiovascular disease increases, the prevalence of this arrhythmia is expected to rise.(2) Much of the morbidity associated with AF is attributable to a 5- to 6-fold increased risk of stroke.”
- Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. (2013, background): “Go et al.(32) estimated that the prevalence of adults with AF in the USAwill rise from2.”
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, background): “Ibutilide is effective, but the risk of serious proarrhythmia is not negligible.(2)”
- Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation: Lessons From a 5-Year Follow-Up (2010, background): “The high success rate in our study may be explained by the facts that (1) only patients with PAF and normal LV function were included, a patient population represented in the majority of previously published studies on catheter ablation of AF10 –14; (2) CPVI was verified by 2 Lasso catheters positio”
- Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. (2005, neutral): “Concomitant disease Hypertension 620 (63) 942 (62) 772 (66) 984 (64) Coronary artery disease 309 (32) 514 (34) 338 (29) 543 (36) Acute infarction 65 (7) 32 (2) 24 (2) 41 (3) Old infarction 124 (13) 228 (15) 142 (12) 259 (17) Previous PCI / CABG 102 (11) 187 (12) 136 (12) 166 (11) Angina 179 (19) 350”